Skip to main content
. Author manuscript; available in PMC: 2011 Aug 15.
Published in final edited form as: Clin Cancer Res. 2010 Aug 3;16(16):4126–4134. doi: 10.1158/1078-0432.CCR-10-0168

Table 1.

SMAD4 immunohistochemistry in juvenile polyps from patients with a SMAD4 germline mutation.

Patient polyp Exon Mutation Effect SMAD4 IHC

normal reduced loss
1 1.1 10 c.1411-1435del25 p.G471FfsX25
1.2 10 c.1411-1435del25 p.G471FfsX25
2* 2.1 8 c.970 T>C p.C324R
2.2 8 c.970 T>C p.C324R
2.3 8 c.970 T>C p.C324R
3* 3.1 8 c.970 T>C p.C324R
3.2 8 c.970 T>C p.C324R
4 4.1 1-11 hemizygous deletion
5 5.1 1-11 hemizygous deletion
5.2 1-11 hemizygous deletion
6 6.1 8 c.989 A>G p.E330G
6.2 8 c.989 A>G p.E330G
6.3 8 c.989 A>G p.E330G
7 7.1 9 c.1193 G>A p.W398X
7.2 9 c.1193 G>A p.W398X
7.3 9 c.1193 G>A p.W398X
8 8.1 8 971delG p.C324FfsX12
8.2 8 971delG p.C324FfsX12
8.3 8 971delG p.C324FfsX12
8.4 8 971delG p.C324FfsX12
*

Patient 2 and 3 and

patient 4 and 5 were from the same family